A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care UnitAlexis Tabah, Jan J. De Waele, Menino Osbert Cotta et al.|Clinical Infectious Diseases|2015Cited by 216
Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trialPeter Pickkers, Johannes G. van der Hoeven, Suzanne Heemskerk et al.|Critical Care|2012Cited by 198
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)Alexis Tabah, José Garnacho‐Montero, Matteo Bassetti et al.|Intensive Care Medicine|2019Cited by 185
Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedureMirjana Stanić Benić, Claudia Wild, Marco Cavaleri et al.|Journal of Antimicrobial Chemotherapy|2018Cited by 159
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA studyLiesbet De Bus, Mónica Crespo, Pieter Depuydt et al.|Intensive Care Medicine|2020Cited by 117